Improving Survival with Thoracic Radiotherapy in Patients with Small Cell Lung Cancer. The CONVERT and the REST Trials

Clinical Oncology

Volumn 22, Issue 7, 2010, Pages 547-549

  Faivre Finn, C ^a   Blackhall, F ^a   Snee, M ^b   Harden, S ^c   Hulse, P ^a   Lorigan, P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^c ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; ETOPOSIDE; PLATINUM DERIVATIVE;

CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EDITORIAL; HUMAN; LUNG SMALL CELL CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL TIME; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 77955655392     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2010.05.008     Document Type: Editorial

References (12)

1. Ferraldeschi R., Baka S., Jyoti B., Faivre-Finn C., Thatcher N., Lorigan P. Modern management of small-cell lung cancer. Drugs 2007, 67(15):2135-2152.
2. Auperin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999, 341(7):476-484.
3. Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357(7):664-672.
4. Bayman N.A., Sheikh H., Kularatne B., et al. Radiotherapy for small-cell lung cancer-where are we heading?. Lung Cancer 2009, 63(3):307-314.
5. Turrisi A.T., Kim K., Blum R., et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Engl J Med 1999, 340(4):265-271.
6. Law A.B., Erridge S.C., MacKean M.J., et al. Improving outcomes for limited stage small cell lung cancer patients in Scotland with concomitant chemoradiation. Clin Oncol (R Coll Radiol) 2007, 19(3):188-193.
7. Baas P., Belderbos J.S., Senan S., et al. Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study. Br J Cancer 2006, 94(5):625-630.
8. De Ruysscher D., Bremer R.H., Koppe F., et al. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. Radiother Oncol 2006, 80(3):307-312.
9. Ishikura S. Quality assurance of radiotherapy in cancer treatment: toward improvement of patient safety and quality of care. Jpn J Clin Oncol 2008, 38(11):723-729.
10. Hou J.M., Greystoke A., Lancashire L., et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 2009, 175(2):808-816.
11. Kamel E.M., Zwahlen D., Wyss M.T., Stumpe K.D., von Schulthess G.K., Steinert H.C. Whole-body (18)F-FDG PET improves the management of patients with small cell lung cancer. J Nucl Med 2003, 44(12):1911-1917.
12. Jeremic B., Shibamoto Y., Nikolic N., et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol 1999, 17(7):2092-2099.